Article
FZR1 loss increases sensitivity to DNA damage and consequently promotes murine and human B-cell acute leukemia
31 Jan 2017
Abstract excerpt
promotes the development of resistant clones. Our results suggest that reduction of FZR1 increases therapeutic sensitivity of B-ALL and that transient rather than tonic inhibition of FZR1 may be a therapeutic strategy.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
